Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_assertion type Assertion NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_head.
- NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_assertion wasGeneratedBy ECO_0000203 NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_provenance.
- NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_assertion wasDerivedFrom befree-20150227 NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_provenance.
- NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_assertion SIO_000772 24311722 NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_provenance.
- NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_assertion evidence source_evidence_literature NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_provenance.
- NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_assertion description "[Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790680.RADiqGlTMEf-Es80w7iaqXLLZ3M_vM5C2LERSoCg1U4gU130_provenance.